Urban demand revives; Akzo gaining market share

Similar documents
Niket Shah

Sohail Halai Alpesh Mehta

Pidilite Industries. CMP: INR164 TP: INR186 Buy

Hardick Bora

Titan Industries. CMP: INR222 TP: INR220 Neutral

Asian Paints. CMP: INR2,722 TP: INR3,161 Buy

Sanjay Jain Pavas Pethia

Jubilant Foodworks. CMP: INR1,189 TP: INR1,0541,054 Neutral

Stress test: Weak capital servicing ratios to drive pricing discipline

CMP: INR350 TP: INR375 Downgrade to Neutral

Canara Bank. CMP: INR419 TP: INR525 Buy

Jaypee Infratech. CMP: INR33 TP: INR45 Buy

CMP: INR415 TP: INR 471 BUY

NTPC CMP: INR169 TP: INR191 Buy

Siddharth Bothra

IndusInd Bank. CMP: INR345 TP: INR419 Buy

CPCB-2: Important long-term driver

Market share recovery, price hike, content leverage to drive growth

Jinesh Gandhi Chirag Jain

Reliance Infrastructure CMP: INR528

Amara Raja Batteries. CMP: INR517 TP: INR560 Buy

Hardick Bora 4QCY12 Results Update Sector: Healthcare Sanofi India CMP: INR2,307 TP: INR2,015 Neutral

Sandipan Pal QFY13 Results Update Sector: Real Estate Unitech CMP: INR29 TP: INR44 Buy

Coal India CMP: INR348 TP: INR408 Buy

BGR Energy. CMP: INR266 TP: INR230 Neutral

Kotak Mahindra Bank. CMP: INR495 TP: INR429 Neutral

Idea Cellular. CMP: INR159 TP: INR200 Buy

Unitech. CMP: INR20 TP: INR30 Buy

Godrej Consumer Products

Cross service charges at INR m/quarter

Sanofi India. CMP: INR2,200 TP: INR1,848 Neutral

BGR Energy. CMP: INR282 TP: INR253 Neutral

Just Dial. CMP: INR1,129 TP: INR1,475 Buy

Jinesh Gandhi Sandipan Pal

Automobiles. HMSI s expansion could result in short-term pressure on HMCL and BJAUT

Jinesh Gandhi Chirag Jain

Shoppers Stop. CMP: INR339 TP: INR355 Neutral

JSW Steel. CMP: INR670 TP: INR391 Sell Merger with JSW Ispat

CMP: INR121 TP: INR193 Buy

CMP: INR826 TP: INR810 (-2%) Neutral

Larsen & Toubro. CMP: INR1,160 TP: INR1,417 Buy

Kotak Mahindra Bank. CMP: INR626 TP: INR500 Neutral

Cement. Demand to grow 8%, with cost push to be passed on CCI probe to have limited impact

Punjab National Bank. CMP: INR716 TP: INR950 Buy

IDBI Bank. CMP: INR106 TP: INR121 Neutral

Individual Housing Loans: Rationalization of Risk-Weights and LTV Ratios

BGR Energy. CMP: INR284 TP: INR296 Neutral

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy

Godrej Properties. CMP: INR368 TP: INR420 Neutral

Torrent Pharmaceuticals

ECOSCOPE. Real GDP growth eases on lower net indirect taxes. The Economy Observer. Real GVA growth exactly as expected

Strides Arcolab. CMP: INR717 TP: INR829 Buy

To voluntarily stop supplies to US

REPORT THREADBARE. New accounting standards from FY The ART of annual report analysis

M&M Financial Services

Hardick Bora QFY13 Results Update Sector: Healthcare Lupin CMP: INR725 TP: INR851 Buy

Jaiprakash Associates

Raymond. Restructuring initiatives bearing fruit; Land bank base case value INR147/share; Reiterate Buy. CMP: INR385 TP: INR462 Buy

CMP: INR124 TP: INR172 Buy. Benefit of two major motorcycle launches not priced in. Improved industry outlook and recent launch success drive upgrades

Alpesh Mehta Sohail Halai

Hardick Bora 4QFY13 Results Update Sector: Healthcare Dr Reddy's Laboratories CMP: INR2,026 TP: INR2,375 Buy

Dabur India. CMP: INR130 TP: INR135 Neutral

Idea Cellular. CMP: INR81 TP: INR Under Review

Shree Renuka Sugars. CMP: INR26 TP: INR45 Buy

Jubilant Foodworks. CMP: INR1,051 TP: INR1,054 Neutral

Petronet LNG. CMP: INR146 TP: INR205 Buy

Dabur India. CMP: INR106 TP: INR94 Neutral

Maruti Suzuki. CMP: INR1,395 TP: INR1,730 Buy

Canara Bank. CMP: INR464 TP: INR645 Buy

CMP: INR320 TP: INR164(-49%) Sell Intending to exit UK execution is key!

KPIT Technologies. CMP: INR175 TP: INR170 Downgrade to Neutral

Gautam Duggad Sreekanth P V S

Hindalco. CMP: INR113 TP: INR151 Buy

Axis Bank. CMP: INR1,119 TP: INR1,330 Buy

Cummins India. CMP: INR430 TP: INR462 Neutral

Decent performance by the sector in a tough quarter

Godrej Consumer Products

Godawari Power & Ispat

Punjab National Bank. CMP: INR768 TP: INR963 Buy

Oberoi Realty. CMP: INR264 TP: INR315 Buy

Oberoi Realty. CMP: INR240 TP: INR297 Buy

Asian Paints. Valuations no longer euphoric; upgrade to Buy. CMP: INR729 TP: INR840 (+15%) Upgrade to Buy

Financial integrity intact; FDA resolution the key

Tribhovandas Bhimji Zaveri

CMP: INR859 TP: INR810 (-6%) Neutral

City Union Bank BUY. 24 February 2016 INR82

Expect capacity-led rerating; maintain Buy

Hindustan Unilever. CMP:INR324 TP:INR302 Neutral

No significant jump in retail electronic payments post demonetization

PVR Ltd. CMP: INR685 TP: INR750 Buy

CMP: INR615 TP: INR755(+23%) Buy Nominee Gold has some new competition on the block

BHEL. CMP: INR227 TP: INR233 Neutral

No major improvement in value proposition expected

Punjab National Bank. CMP: INR940 TP: INR1,275 Buy

Larsen & Toubro. CMP: INR1,278 TP: INR1,380 Buy

Monnet Ispat. CMP: INR449 TP: INR518 Neutral

CMP: INR1,044 TP: INR970 (-7%) Neutral Sale of Healthcare business margin accretive

ECOSCOPE. 3QFY16 CAD/GDP corrects to 1.3% The Economy Observer. Balance of Payments. See surplus in 4Q and to remain low in FY17; INR to correct still

Axis Bank. CMP: INR1,008 TP: INR1,240 Buy

Jindal Steel & Power. CMP: INR274 TP: INR379 Buy

Transcription:

BSE Sensex S&P CNX 22,095 6,601 CMP: INR889 26 March 2014 Update Sector: Consumer Not Rated Urban demand revives; Akzo gaining market share Reiterates focus on Profitable growth Urban demand for Decorative Paints has been picking up in the last six months, according to the management of (AKZO). This contrasts with the commentaries by Staple companies where consumer demand is yet to see meaningful recovery. In our recent meeting, the management also highlighted the stickiness in receivables from dealers in Central and Eastern India. Election funding could be one of the issues. AKZO is gaining traction in the mid-end segment. Given the higher salience of urban markets in its revenues, it should benefit from the revival in urban demand. It is targeting 100bp market share gain annually, with focus on profitable growth. The stock trades at 18.2x FY15 consensus EPS. Not Rated. Pick-up in urban demand for Decorative Paints AKZO has seen a pick-up in urban demand over the last six months. The management believes this is largely driven by improved consumer sentiment in urban markets. While revival in urban demand applies to the entire Paints industry, AKZO is benefiting more due to higher salience of urban markets in its revenues. Though consumer inflation has been sticky, AKZO believes that Paints demand cannot be postponed indefinitely. Hence, Decorative Paints volumes have not seen much worsening. This contrasts with the commentaries by Staple companies where consumer demand is yet to see meaningful recovery and is likely to remain subdued till 1HFY15. The management pointed towards stickiness of receivables from certain dealers in Central and Eastern India. Election-related funding could be one of the reasons. To enforce payment discipline among its dealers, AKZO halts shipments to dealers crossing a certain credit limit. 9MFY14 sales up 6.8 % Sales (INR m) Sales gr (%) 22,320 19,878 81.2% 9,978 10,417 10,968 18,064 7.3% 4.4% 5.3% 12.3% 6.8% FY09 FY10 FY11 FY12 FY13 9MFY14 Gautam Duggad (Gautam.Duggad@MotilalOswal.com); +91 22 3982 5404 Manish Poddar (Manish.Poddar@MotilalOswal.com); +91 22 3027 8029 Investors are advised to refer through disclosures made at the end of the Research Report.

Industrial Paints still sluggish Demand for Industrial Paints has remained weak due to macroeconomic uncertainty and slowdown in infrastructure spending. According to the management, there has been some pick-up in Automotive Coatings. However, AKZO operates only in the Refinishes segment and does not service OEM clients. Protective Coatings, demand for which is a derivative of infrastructure spends, are yet to see any recovery and may track improvement in macro parameters. Power and Coil Coatings are growing ahead of the market, though at a modest rate of 6-7%. Raw material costs stable; Gwalior plant to drive margin expansion The raw material environment for Paints has been stable. Hence, flexibility to implement price hikes is lower. Given AKZO s focus on building its mid-end portfolio and lack of pricing levers, its gross margin could be impacted. However, the management believes savings from manufacturing efficiencies at the Gwalior plant can boost gross margin. The Gwalior plant will have a different manufacturing process and superior back-cycle time than existing plants. While gross margin might expand, rising royalty rates could prevent a flow of the benefits to EBITDA. Royalty for Decorative Paints is expected to rise from 1.2% to 2.2% post 3QFY15. Royalty for Industrial Paints is 4-6%. AKZO is also undertaking various consumer initiatives to drive market share gains consumer engagement through Dulux Decorator Center, competitive brand spends, etc. We expect gross margin to remain stable in the best case scenario, given the multiplicity of factors at work: (a) mix impact owing to focus on mid-end portfolio, (b) competitive ad spends driving market share gains, and (c) rising royalty rates. Gwalior plant to drive gross margin expansion Gross Margin (%) EBITDA Margin (%) 55.3% 59.8% 47.3% 42.7% 42.0% 42.8% 10.2% 11.3% 12.1% 8.8% 8.4% 7.1% FY09 FY10 FY11 FY12 FY13 9MFY14 26 March 2014 2

Ad spends (% of Sales) Royalty (% of Sales) set to increase from 3QFY15 onwards 21.1 2.2 16.7 1.7 13.5 1.2 9.5 8.4 0.6 0.8 FY09 FY10 FY11 FY12 FY13 FY09 FY10 FY11 FY12 FY13 Reiterates focus on Profitable growth; EUR1b target deferred AKZO had initially articulated its goal of EUR1b sales by 2016. However, as part of its global strategy realignment, this goal is deferred to 2018, and timelines are not sacrosanct. The company s key focus is to drive profitable growth and gain 100bp market share annually. Unlike its peers that are driving premiumization, AKZO is trying to build its presence in the mid-end and lower-end segments. While this has gross margin repercussions, the management believes better scale and manufacturing efficiencies will provide operating leverage, helping to offset any gross margin contraction. AKZO s strength lies in the Premium segment (Dulux Velvet), where it enjoys 20% plus market share and is the second largest player after Asian Paints (APNT). Its share in the mid-market segment is a miniscule 5-6%, which it is looking to expand by augmenting its dealer network (8,500 dealers; ~1/4th of APNT s network) and enhancing its product portfolio. In this segment, Dulux Promise and Dulux Rainbow are doing well and beating internal benchmarks. In the lower-end segment, AKZO has its ICI brand. We believe strong R&D capabilities are a key competitive advantage for AKZO. According to the management, innovation will be a key strategy. Products launched in the last 24 months now constitute 20% of its portfolio. Akzo s mid-end portfolio gaining traction; meeting internal benchmarks 26 March 2014 3

Other takeaways AKZO s total capacity stands at 200m liters, which should be enough to meet demand for the next two years. AKZO is expanding its dealer network across the metro cities as well as tier-ii towns. The management believes dealer satisfaction will increase with scale, though it is difficult to address fill rates to the satisfaction of all dealers across geographies. Typically, AKZO follows the industry leader in pricing decisions. Financial Snapshot (INR m) Y/E March FY10 FY11 FY12 FY13 9MFY14 Net Sales 10,417 10,968 19,878 22,320 18,064 Change (%) 4.4% 5.3% 81.2% 12.3% Total Expenditure 9,241 9,637 18,132 20,435 16,779 EBITDA 1,176 1,331 1,746 1,885 1,285 Change (%) 16.0% 13.2% 31.2% 8.0% Margin (%) 11.3% 12.1% 8.8% 8.4% 7.1% Depreciation 212 217 366 386 320 Int. and Fin. Charges 11 15 39 89 13 Other Income 1,047 1,100 1,123 1,381 341 Profit before Taxes 2,000 2,199 2,464 2,791 1,294 Change (%) -47.2% 9.9% 12.1% 13.3% Margin (%) 19.2% 20.0% 12.4% 12.5% 7.2% Tax 444 413 433 582 338 Deferred Tax (37) 20 13 21 - Tax Rate (%) 20.4% 19.7% 18.1% 21.6% 26.1% Profit after Taxes 1,593 1,766 2,018 2,188 956 Change (%) -45.9% 10.9% 14.3% 8.4% Margin (%) 15.3% 16.1% 10.2% 9.8% 5.3% Extraordinary income 639 550 718 813 - Reported PAT 954 1216 1300 1375 956 26 March 2014 4

N O T E S 26 March 2014 5

Disclosures This report is for personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This report is intended for distribution to institutional investors. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement AKZO NOBEL 1. Analyst ownership of the stock No 2. Group/Directors ownership of the stock No 3. Broking relationship with company covered No 4. Investment Banking relationship with company covered No Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.K. This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to which this document relates is only available to investment professionals and will be engaged in only with such persons. For U.S. Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered brokerdealer, MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. For Singapore Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited: Anosh Koppikar Kadambari Balachandran Email:anosh.Koppikar@motilaloswal.com Email : kadambari.balachandran@motilaloswal.com Contact(+65)68189232 Contact: (+65) 68189233 / 65249115 Office Address:21 (Suite 31),16 Collyer Quay,Singapore 04931 Motilal Oswal Securities Ltd Motilal Oswal Tower, Level 9, Sayani Road, Prabhadevi, Mumbai 400 025 Phone: +91 22 3982 5500 E-mail: reports@motilaloswal.com 26 March 2014 6